Komori
COSMOS Pharmaceutical (3349) · RiskRestated

Identifying Climate-Related Risks and Opportunities and TCFD Disclosure

First written in FY2023. 2 of 3 entries say "Restated". Latest entry: FY2026.

3entries
4years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2023 – FY20262023: 120232024: 120242025: 020252026: 12026
Same theme, other companies
TCFD-Based Climate Change Scenario Analysis and DisclosureA theme 558 companies write about · 115 as a headwind · 328 as a tailwind

36 other companies' latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 195 companies compared. The sentences above are computed from all 195.Comparing 200 of the theme's 574 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2026RestatedAnnual report

    「Climate-related risks and opportunities may arise from the transition to a low-carbon society, including regulations concerning greenhouse-gas emissions, or from physical changes caused by climate change, such as more severe climate disasters. Our group classifies and evaluates these risks and opportunities as shown below and analyzes their impact on business strategy.」

    The Company continues to organize and evaluate transition risks, physical risks and opportunities under the TCFD framework and analyze their impact on its business strategy.
  2. FY2024RestatedAnnual report

    「Climate-related risks and opportunities may arise from the transition to a low-carbon society, including regulations concerning greenhouse-gas emissions, or from physical changes caused by climate change, such as more severe climate disasters. Our group classifies and evaluates these risks and opportunities as shown below and analyzes their impact on business strategy.」

    The Company continues to organize carbon prices, fluorocarbon regulations, electricity prices, consumer changes, extreme weather and rising temperatures as risks and opportunities under the TCFD framework.
  3. FY2023First statedAnnual report

    「Climate-related risks and opportunities may arise from the transition to a low-carbon society, including regulations concerning greenhouse-gas emissions, or from physical changes caused by climate change, such as more severe climate disasters. Our group classifies and evaluates these risks and opportunities as shown below and analyzes their impact on business strategy.」

    In line with the four TCFD disclosure areas, the company classifies carbon prices, fluorocarbon regulations, electricity prices, consumer changes, extreme weather and rising temperatures as transition risks, physical risks or opportunities.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for COSMOS Pharmaceutical yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.